The Global Next-Generation Biomanufacturing market is growing at an exponential rate on an account of the rising adoption of innovative technologies and methods to upsurge productivity & flexibility and to reduce manufacturing plant footing and cost. Moreover, the increasing demand for immunotherapy drugs and the growing aging population with chronic diseases such as cancer, cardiovascular and respiratory diseases. Along with the setup of biomanufacturing plants in different countries such as Singapore and growing demand for advanced biomanufacturing practices to treat the rising patient population has encouraged the development of next-generation biomanufacturing products.
According to MarkNtel Advisors’ research report titled “Global Next-Generation Biomanufacturing Market Analysis, 2020”, the Global Next-Generation Biomanufacturing market is anticipated to grow at a CAGR of around 25% during 2020-25. Based on the Application, Vaccine captured the majority market share in 2019 due to the growing demand for new vaccine and burgeoning therapy production methods to increase capacity, scalability, and flexibility.
“Global Next-Generation Biomanufacturing Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and growth opportunities available for Next-Generation Biomanufacturing providers across the globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.
North America Acquired the Majority Market Share
North America acquired a significant market share in Global Next-Generation Biomanufacturing in 2019. USA dominated the North American market on an account of extensive government investment for the development next-generation biomanufacturing due to a growing number of patients with serious diseases and spur in the treatments for many orphan diseases. Moreover, considerable advancement in technology coupled with rising discovering, developing, and manufacturing of innovative human therapeutics and expansion in the number of targeted products is anticipated fuel the demand for the Global Next-Generation Biomanufacturing market in this region as stated in MarkNtel Advisors’ research report “Global Next-Generation Biomanufacturing Market Analysis, 2020”.
According to MarkNtel Advisors, the key players with a considerable market share in the Global Next-Generation Biomanufaon Biote B.V., bbi-bech GmbH, Meissner Filtration Products Inc., Merck KGaA, Danaher Corporation, Eppendorf AG, Esco Micro Pte. Ltd., PBS Biotech Inc., Solaris Biotechnology Srl.
Key questions answered in the study: